Medpace Holdings Inc
Slēgts
SektorsVeselības aprūpe
458.38 0.52
Pārskats
Akcijas cenas izmaiņa
24h
Min
455.98
Max
460.92
Ienākumi | -11M 124M |
|---|---|
Pārdošana | -1.8M 707M |
P/E Sektora vidējais | 29.031 49.712 |
EPS | 4.28 |
Peļņas marža | 17.53 |
Darbinieki | 6,300 |
EBITDA | -9.5M 154M |
Rekomendācijas | Pirkt |
|---|---|
Prognoze 12 mēnešiem | -1.73% downside |
Nākamie ieņēmumi | 2026. g. 22. jūl. |
|---|
Tirgus kapitalizācija | -1.9B 13B |
|---|---|
Iepriekšējā atvēršanas cena | 457.86 |
Iepriekšējā slēgšanas cena | 458.38 |
Ziņu noskaņojums
By Acuity
26%
74%
54 / 342 Rangs Healthcare
Medpace Holdings Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.